#Legacy family tree portable portable
Usage of portable ECG facilities in various forms such as single lead and 12-lead handheld instruments has been studied by many for effective management and early identification of cardiac abnormalities in various health care settings ( 3– 5). Prompt screening, early identification of true cases and prompt management, especially with thrombolytic and aspirins with timely referral in “GOLDEN HOUR” (the first 60 min of a heart attack) is, of utmost importance. Advancement in diagnostic methods has provided handheld portable electrocardiography (ECG) technology that can effectively screen some cardiac abnormalities in the absence of conventional ECG machines, especially at the PHC level. About 23% of those with heart attacks do not survive due to delay in treatment leading to the death of around 1.7 million Indians ( 2).Ĭonsidering the silent progression of the disease and the requirement of specific expertise for diagnosis and treatment, early diagnosis and treatment facilities are extremely limited at primary health centers (PHCs). In India, 26% risk of death can be attributed to CVDs. Globally 70% of all deaths are due to non-communicable diseases (NCDs) ( 1). Results are sensitive to the relative risk reduction associated with the non-participation and the cost of initial screening.Ĭonclusion: Cost-effectiveness analysis clearly shows that the facility to screen cardiac abnormality at the PHC level is highly recommended for high-risk adults and symptomatic cases.Ĭardiovascular diseases (CVD) are emerging as the number one cause of death across the globe. The budget impact analysis was also performed. Results: The ECG screening at PHC saves 2.90 life years at an incremental cost of 89.97 USD (6657.47 INR), yielding a cost-effectiveness ratio of 31.07 USD (2,299.06 INR) per life-year saved, which is below the willingness to pay threshold. Transition probabilities were derived from primary data supported by expert opinion for the intervention arm, while a systematic search of the literature was undertaken to derive transition probabilities for the control arm. The program cost was obtained from the implementers. We surveyed 73 patients who screened positive for cardiac abnormality, documented the type of ECG abnormalities, and diagnosed CVD.
An incremental costing approach was adapted, and cost-effectiveness analysis was done using a decision-analytic model. Methods: Cost-effective analysis was conducted using a societal perspective. The prime purpose of the study was to assess the cost-effectiveness of portable ECG for the screening of cardiovascular diseases (CVD) among high-risk and symptomatic adults at the PHC in Ahmedabad, Gujarat. Background: District Health Authority in Ahmedabad, Gujarat has introduced Project Lifeline, 12-lead portable ECG devices across all primary health centers (PHC) in the district to screen cardiac abnormalities among high-risk and symptomatic adults for providing primary management and proper timely referral.
0 kommentar(er)
